Skip over navigation
Directory
Directory Search
Jobs
Job Search
Post a Job
Patient
Patient Resources
Drug Development
History
Genealogy
Toons & Teasers
About
Advertising
Home
Quick Links
Directory
Job Search
Toons & Teasers
Advertising
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Industry News
Search Articles:
Novo Nordisk files oral semaglutide for US regulatory approval of glycaemic control
Novo Nordisk announced the submission of two NDAs to the FDA for oral semaglutide, a once-daily glucagon-like peptide-1 (GLP-1) analogue in a tablet, as well as a supplemental NDA for once-weekly Ozempic® (semaglutide).
March 20, 2019
More...
Email This Page
to a Friend
Print This
Page